Gatekeepers of the Gut: The Roles of Proteasomes at the Gastrointestinal Barrier
Open Access
- 5 July 2021
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 11 (7), 989
- https://doi.org/10.3390/biom11070989
Abstract
The gut epithelial barrier provides the first line of defense protecting the internal milieu from the environment. To circumvent the exposure to constant challenges such as pathogenic infections and commensal bacteria, epithelial and immune cells at the gut barrier require rapid and efficient means to dynamically sense and respond to stimuli. Numerous studies have highlighted the importance of proteolysis in maintaining homeostasis and adapting to the dynamic changes of the conditions in the gut environment. Primarily, proteolytic activities that are involved in immune regulation and inflammation have been examined in the context of the lysosome and inflammasome activation. Yet, the key to cellular and tissue proteostasis is the ubiquitin–proteasome system, which tightly regulates fundamental aspects of inflammatory signaling and protein quality control to provide rapid responses and protect from the accumulation of proteotoxic damage. In this review, we discuss proteasome-dependent regulation of the gut and highlight the pathophysiological consequences of the disarray of proteasomal control in the gut, in the context of aberrant inflammatory disorders and tumorigenesis.Funding Information
- European Research Council (677748)
- Merck KGaA (2109/18)
This publication has 116 references indexed in Scilit:
- The Ubiquitin CodeAnnual Review of Biochemistry, 2012
- NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB SignalingImmunity, 2012
- Regulation of NF‐κB by ubiquitination and degradation of the IκBsImmunological Reviews, 2012
- Mice completely lacking immunoproteasomes show major changes in antigen presentationNature Immunology, 2011
- Phosphorylation-dependent regulation of SCFFbx4 dimerization and activity involves a novel component, 14-3-3ɛOncogene, 2011
- The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental ColitisImmunity, 2010
- The effect of proteasome inhibitor MG132 on experimental inflammatory bowel diseaseClinical and Experimental Immunology, 2009
- Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insultsMutation Research - Reviews in Mutation Research, 2008
- Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen speciesThe EMBO Journal, 2007
- Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitisJCI Insight, 2006